DE69938939D1 - Pharmazeutische Zusammensetzung enthaltend Beclomethason-Dipropional zur Behandlung entzündlicher Darmerkrankungen - Google Patents

Pharmazeutische Zusammensetzung enthaltend Beclomethason-Dipropional zur Behandlung entzündlicher Darmerkrankungen

Info

Publication number
DE69938939D1
DE69938939D1 DE69938939T DE69938939T DE69938939D1 DE 69938939 D1 DE69938939 D1 DE 69938939D1 DE 69938939 T DE69938939 T DE 69938939T DE 69938939 T DE69938939 T DE 69938939T DE 69938939 D1 DE69938939 D1 DE 69938939D1
Authority
DE
Germany
Prior art keywords
treatment
inflammatory bowel
bowel disease
dipropional
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69938939T
Other languages
English (en)
Inventor
Paolo Chiesi
Rossella Musa
Eva Bernini
Gian Nicola Castiglione
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiesi Farmaceutici SpA
Original Assignee
Chiesi Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA
Application granted granted Critical
Publication of DE69938939D1 publication Critical patent/DE69938939D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DE69938939T 1998-07-28 1999-07-20 Pharmazeutische Zusammensetzung enthaltend Beclomethason-Dipropional zur Behandlung entzündlicher Darmerkrankungen Expired - Lifetime DE69938939D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI001741A IT1301947B1 (it) 1998-07-28 1998-07-28 Formulazioni farmaceutiche di beclometasone dipropionato per iltrattamento di malattie infiammatorie croniche della mucosa

Publications (1)

Publication Number Publication Date
DE69938939D1 true DE69938939D1 (de) 2008-07-31

Family

ID=11380533

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69938939T Expired - Lifetime DE69938939D1 (de) 1998-07-28 1999-07-20 Pharmazeutische Zusammensetzung enthaltend Beclomethason-Dipropional zur Behandlung entzündlicher Darmerkrankungen
DE69925491T Expired - Lifetime DE69925491T2 (de) 1998-07-28 1999-07-20 Pharmazeutische zusammensetzung enthaltend beclomethason-dipropionat zur behandlung entzündlicher darmerkrankungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69925491T Expired - Lifetime DE69925491T2 (de) 1998-07-28 1999-07-20 Pharmazeutische zusammensetzung enthaltend beclomethason-dipropionat zur behandlung entzündlicher darmerkrankungen

Country Status (9)

Country Link
EP (2) EP1100481B1 (de)
AT (2) ATE296092T1 (de)
AU (1) AU5411999A (de)
DE (2) DE69938939D1 (de)
DK (1) DK1100481T3 (de)
ES (1) ES2243068T3 (de)
IT (1) IT1301947B1 (de)
PT (1) PT1100481E (de)
WO (1) WO2000006132A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60237363D1 (de) * 2001-03-15 2010-09-30 Soligenix Inc Verfahren zur behandlung von entzündlichen erkrankungen des verdauungstrakts mit topisch wirksamen kortikosteroiden
AU2003270815A1 (en) * 2002-09-20 2004-04-08 The Board Of Regents Of The University Of Texas System Treatment of irritable bowel syndrome and related bowel diseases
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350690A (en) * 1980-10-27 1982-09-21 Cressington Investments Ltd. Steroid composition
IT1222414B (it) * 1987-07-31 1990-09-05 Chiesi Farma Spa Composizioni farmaceutiche contenenti trapidil,loro procedimento di preparazione e relaticvo impiego terapeutico
IL92343A0 (en) * 1988-12-20 1990-07-26 Gist Brocades Nv Granulate for multiparticulate controlled release oral compositions,their preparation and oral pharmaceutical compositions containing them
WO1992016214A1 (en) * 1991-03-15 1992-10-01 Norwich Eaton Pharmaceuticals Inc. The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
DK0586488T3 (da) * 1991-06-07 1995-09-04 Byk Nederland Bv Farmaceutisk klysterpræparat
GB9414699D0 (en) * 1994-07-21 1994-09-07 Slagel David Aqueous foamable composition
AU710109B2 (en) * 1996-01-16 1999-09-16 Ap Pharma, Inc. Topical delivery of drugs to the lower gastrointestinal tract
DE69824748T2 (de) * 1997-09-26 2005-08-25 Celltech Pharma Europe Ltd. Pharmazeutische zusammensetzung für die behandlung von enzündlichen darmerkrankungen

Also Published As

Publication number Publication date
EP1486209B1 (de) 2008-06-18
ATE398454T1 (de) 2008-07-15
DE69925491D1 (de) 2005-06-30
DE69925491T2 (de) 2006-02-02
EP1100481B1 (de) 2005-05-25
EP1100481A2 (de) 2001-05-23
WO2000006132A2 (en) 2000-02-10
EP1486209A2 (de) 2004-12-15
IT1301947B1 (it) 2000-07-20
PT1100481E (pt) 2005-09-30
ITMI981741A1 (it) 2000-01-28
DK1100481T3 (da) 2005-09-05
EP1486209A3 (de) 2004-12-22
ES2243068T3 (es) 2005-11-16
AU5411999A (en) 2000-02-21
ITMI981741A0 (it) 1998-07-28
ATE296092T1 (de) 2005-06-15
WO2000006132A3 (en) 2000-04-27

Similar Documents

Publication Publication Date Title
EA200001125A1 (ru) Гелеобразные фармацевтические композиции
HRP20060251A2 (en) Substituted oxasolidinones and their use
TR200100894T2 (tr) Aril ikameli propanolamin türevleri, imalat yöntemleri, ilaç maddeleri, kullanımları.
ATE396967T1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
TR200102817T2 (tr) Antiinflamatuar ajanlar olarak faydalı bileşikler
IS6557A (is) Blandaðar sjúkdómsmeðferðir úr blóðþrýstingslækkandi efnum og efnum sem hamla æðamyndun
LU91281I2 (fr) Preotact-hormone parathyroïde
ATE431149T1 (de) Analoge der barbitursäure als therapeutische wirkstoffe
MA28038A1 (fr) Thienopyrazoles
CU23241B7 (es) 2-fenil-1-(4(2-aminoetoxi)-benzil)-indol en combinacion con estrogenos
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
PT994710E (pt) Composicoes farmaceuticas administraveis por via oral incluindo uma benzidrilpiperazina e uma ciclodextrina
DE60213404D1 (de) Verwendung von sulodexid zur behandlung von reizdarm
ATE451123T1 (de) Vaginal verabreichbare zusammensetzung zur behandlung von uteriner dysrhythmie
BG106155A (en) Novel derivatives and analogues of galanthamin
DE60334711D1 (de) Zusammensetzungen aus ezetimib und verfahren zur behandlung von mit cholesterin zusammenhängenden gutartigen und bösartigen tumoren
DE60031016D1 (de) Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen
DE69938939D1 (de) Pharmazeutische Zusammensetzung enthaltend Beclomethason-Dipropional zur Behandlung entzündlicher Darmerkrankungen
HUP9802897A2 (hu) Optikailag aktív piridil-4H-1,2,4-oxadiazin-származék, annak alkalmazása vaszkuláris betegségek kezelésére, valamint ilyen származékot hatóanyagként tartalmazó gyógyászati készítmény
DK0917460T3 (da) Cyclosporin-formulering
TR200100897T2 (tr) Lipid metabolizma bozukluklarının tedavisinde safra asitleriyle bağlı propanolamin türevleri.
DE60311351D1 (de) Verwendung von Zeoliten zur Herstellung oraler Zubereitungen zur Behandlung von Vergiftung
DK0853476T5 (da) Nimesulidholdigt farmaceutisk præparat til topisk anvendelse
EA200400348A1 (ru) Цисплатиновые составы пониженной токсичности и способы их применения
ATE232541T1 (de) Gallensauersälze mit physiologisch aktiven metalle und ihre verwendung zur therapeutischen behandlung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition